Hot-melt extrusion

American Pharmaceutical Review

Volumn 12, Issue 6, 2009, Pages 18-27

  Repka, Michael A ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; DRUG ADDITIVE; PLASTICIZER; POLYMER; SOLVENT; WATER;

AQUEOUS SOLUTION; BIOAVAILABILITY; COMBINATORIAL CHEMISTRY; CONTROLLED RELEASE FORMULATION; COOLING; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG MANUFACTURE; DRUG MIXTURE; DRUG RELEASE; DRUG STABILITY; GEL PERMEATION CHROMATOGRAPHY; HEATING; HOT MELT EXTRUSION TECHNOLOGY; LIPOPHILICITY; LOW TEMPERATURE; MELTING POINT; METALLURGY; NANOPHARMACEUTICS; NANOTECHNOLOGY; PATENT; PELLET EXTRUSION; PLASTIC INDUSTRY; REVIEW; SUSPENDED PARTICULATE MATTER; SUSTAINED DRUG RELEASE; THERMAL ANALYSIS; THERMOGRAVIMETRY; VALIDATION PROCESS;

EID: 70350576321     PISSN: 10998012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Crowley MM, Zhang F, Repka MA, Thumma S, Upadhye SB, Battu SK, McGinity JW, Martin C 2007. Pharmaceutical applications of hot-melt extrusion: part I. Drug Dev Ind Pharm 33(9):909-926. (Pubitemid 47463803)
2. Kerns EH 2001. High throughput physicochemical profiling for drug discovery. J Pharm Sci 90(11):1838-1858. (Pubitemid 33062605)
3. Breitenbach J, Magerlein M. 2003. Melt extruded molecular dispersions. In Ghebre-Sellassie I, Martin C, editors. Pharmaceutical Extrusion Technology, ed.: Marcel Dekker, Inc.
4. Forster A, Hempenstall J, Rades T 2001. Characterization of glass solutions of poorly water-soluble drugs produced by melt extrusion with hydrophilic amorphous polymers. J Pharm Pharmacol 53(3):303-315.
5. Kinoshita M, Baba K, Nagayasu A, Yamabe K, Shimooka T, Takeichi Y, Azuma M, Houchi H, Minakuchi K 2002. Improvement of solubility and oral bioavailability of a poorly water-soluble drug, TAS-301, by its melt-adsorption on a porous calcium silicate. J Pharm Sci 91(2): 362-370.
6. Ndindayino F, Vervaet C, van den Mooter G, Remon JP 2002. Direct compression and moulding properties of co-extruded isomalt/drug mixtures. Int J Pharm 235(1-2):159-168. (Pubitemid 34185447)
7. Griff AL. 1968. Plastics Extrusion Technology. 2nd Edition ed., Malabar: Robert E. Krieger Publishing Company. p 1-35.
8. Mollan M. 2003. Historical Overview. In Ghebre-Sellassie I, Martin C, editors. Pharmaceutical Extrusion Technology, ed., New York, Ny: Marcel Dekker, Inc. p 1-18.
9. Breitenbach J 2002. Melt extrusion: from process to drug delivery technology. European Journal of Pharmaceutics and Biopharmaceutics 54:107-117.
10. Steiner R. 2003. Extruder design. In Ghebre-Sellassie I, Martin C, editors. Pharmaceutical Extrusion Technology Drugs and the Pharmaceutical Sciences, ed., New York: Marcel Dekker, Inc. p 19-38.
11. Ghebre-Sellassie I, Martin C. 2003. Future Trends. Pharmaceutical Extrusion Technology Drugs and the Pharmaceutical Sciences, ed., New York: Marcel Dekker. p 383-392.
12. McGinity JW, Zhang F. 2003. Melt-Extruded Controlled- Release Dosage forms. In Ghebre-Sellassie I, Martin C, editors. Pharmaceutical extrusion technology, ed., New York: Marcel Dekker. p 183-208.
13. Follonier N, Doelker E, Cole ET 1994. Evaluation of hot-melt extrusion as a new technique for the production of polymer-based pellets for sustained release capsules containing high loadings of freely soluble drugs. Drug Dev Ind Pharm 20(8):1323-1339. (Pubitemid 24201240)
14. Young CR, Koleng JJ, McGinity JW 2002. Production of spherical pellets by a hot-melt extrusion and spheronization process. Int J Pharm 242(1-2):87-92.
15. Liu J, Zhang F, McGinity JW 2001. Properties of lipophilic matrix tablets containing phenylpropanolamine hydrochloride prepared by hot-melt extrusion. Eur J Pharm Biopharm 52(2):181-190. (Pubitemid 32755897)
16. McGinity JW, Koleng JJ. 1997. Preparation and Evaluation of Rapid-Release Granules using a Novel Hot-Melt Extrusion Technique. Abstracts of Papers. Part 2. Pharmaceutical Technology Conference, Athens, Greece, p. 153-154.
17. Robinson JR, McGinity JW. Delmas P., 2003. Effervescent granules and methods for their preparation; United States Patent #6,649,186, November 18, 2003.
18. Crowley MM, Zhang F, Koleng JJ, McGinity JW 2002. Stability of polyethylene oxide in matrix tablets prepared by hot-melt extrusion. Biomaterials 23(21):4241-4248. (Pubitemid 34814993)
19. McGinity JW, Zhang F. 2. Hot-melt extrudable pharmaceutical formulation; United States Patent #6,488,963, December 3, 2002.
20. Zhang F, McGinity JW 1999. Properties of sustained-release tablets prepared by hot-melt extrusion. Pharm Dev Technol 4(2):241-250. (Pubitemid 29211025)
21. Zhang F, McGinity JW 2000. Properties of hot-melt extruded theophylline tablets containing poly(vinyl acetate). Drug Dev Ind Pharm 26(9):931-942. (Pubitemid 30471039)
22. Sherry R. 2007. Granules comprising paracetamol, a NSAID and a sugar alcohol made by melt extrusion. ed.: Reckitt Benckiser Healthcare (UK) Limited
23. Rocca JCG. 1993. Stability and Physical-mechanical Properties of Acrylic Resin Copolymers. ed., Austin: University of Texas at Austin.
24. Aitken-Nichol C, Zhang F, McGinity JW 1996. Hot melt extrusion of acrylic films. Pharm Res 13(5):804-808. (Pubitemid 26160100)
25. Repka MA, Gerding TG, Repka SL, McGinity JW 1999. Influence of plasticizers and drugs on the physical-mechanical properties of hydroxypropylcellulose films prepared by hot melt extrusion. Drug Dev Ind Pharm 25(5):625-633.
26. Repka MA, McGinity JW 2001. Influence of chlorpheniramine maleate on topical hydroxypropylcellulose films produced by hot-melt extrusion. Pharm Dev Technol 6(3):297-304. (Pubitemid 32678235)
27. Repka MA, McGinity JW 2000. Physical-mechanical, moisture absorption and bioadhesive properties of hydroxypropylcellulose hot-melt extruded films. Biomaterials 21(14):1509-1517.
28. Repka MA, McGinity JW 2000. Influence of vitamin E TPGS on the properties of hydrophilic films produced by hot-melt extrusion. Int J Pharm 202(1-2):63-70.
29. Thumma S, Majumdar S, Elsohly MA, Gul W, Repka MA 2008. Chemical stability and bioadhesive properties of an ester prodrug of Delta(9)- tetrahydrocannabinol in poly(ethylene oxide) matrices: Effect of formulation additives. Int J Pharm 362(1-2):126-132.
30. Repka MA, Gutta K, Prodduturi S, Munjal M, Stodghill SP 2005. Characterization of cellulosic hot-melt extruded films containing lidocaine. Eur J Pharm Biopharm 59(1):189-196. (Pubitemid 39573452)
31. Prodduturi S, Manek RV, Kolling WM, Stodghill SP, Repka MA 2005. Solid-state stability and characterization of hot-melt extruded poly(ethylene oxide) films. J Pharm Sci 94(10):2232-2245. (Pubitemid 41665283)
32. Munjal M, Elsohly MA, Repka MA 2006. Polymeric systems for amorphous Delta9-tetrahydrocannabinol produced by a hot-melt method. Part II: Effect of oxidation mechanisms and chemical interactions on stability. J Pharm Sci 95(11):2473-2485. (Pubitemid 44726387)
33. Munjal M, Stodghill SP, Elsohly MA, Repka MA 2006. Polymeric systems for amorphous Delta 9-tetrahydrocannabinol produced by a hot-melt method. Part I: chemical and thermal stability during processing. J Pharm Sci 95(8):1841-1853. (Pubitemid 44229590)
34. Mididoddi PK, Prodduturi S, Repka MA 2006. Influence of tartaric acid on the bioadhesion and mechanical properties of hot-melt extruded hydroxypropyl cellulose films for the human nail. Drug Dev Ind Pharm 32(9):1059-1066. (Pubitemid 44521823)
35. Mididoddi PK, Repka MA 2007. Characterization of hot-melt extruded drug delivery systems for onychomycosis. Eur J Pharm Biopharm 66(1):95-105.
36. Sam AP 1992. Controlled release contraceptive devices: a status report. J Control Release 22:35-46.
37. Bhardwaj R, Blanchard J 1997. In vitro evaluation of Poly (d, l-lactide-co-glycolide) polymer-based implants containing the alpha-melanocyte stimulating hormone analog, Melanotan-I. J Control Release 45(1):49-55.
38. Bhardwaj R, Blanchard J 1998. In vitro characterization and in vivo release profile of a poly (,-lactide-co-glycolide)-based implant delivery system for the [alpha]-MSH analog, melanotan-I. Int J Pharm 170(1):109-117.
39. Robinson JR, McGinity JW, Delmas P. 2001. Effervescent granules and methods for their preparation; WIPO, WO/2001/080822.
40. McGinity JW, Robinson JR. 2001. Efferevescence polymeric film drug delivery system; United States patent application 20010006677.
41. Sun Y, Rui Y, Wenliang Z, Tang X 2008. Nimodipine semi-solid capsules containing solid dispersion for improving dissolution. Int J Pharm 359(1-2):144-149.
42. Dong Z, Chatterji A, Sandhu H, Choi DS, Chokshi H, Shah N 2008. Evaluation of solid state properties of solid dispersions prepared by hot-melt extrusion and solvent co-precipitation. Int J Pharm 355(1-2):141-149.
43. Fukuda M, Peppas NA, McGinity JW 2006. Floating hot-melt extruded tablets for gastroretentive controlled drug release system. J Control Release 115(2):121-129.
44. W. Deng, J. Lu, S. Maddineni, T. Hingorani, S. Majumdar, Repka, MA. Influence of Eudragit RS PO and Processing Conditions of Hot-Melt Extrusion on Drug Stability and Dissolution Properties. American Association of Pharmaceutical Scientists Annual Meeting, Los Angeles Convention Center, Los Angeles, CA, November 8-12, 2009; Accepted for Presentation.
45. Miller DA, McConville JT, Yang W, Williams RO, III, McGinity JW 2007. Hot-melt extrusion for enhanced delivery of drug particles. J Pharm Sci 96(2):361-376. (Pubitemid 46363567)
46. S. Maddineni S. Battu, K. Kolter, N. Langley, M. A. Repka. Effect of Processing Conditions on Stability and Drug Release from Nifedipine- Kollidon® VA 64 Hot-Melt Extrudates. American Association of Pharmaceutical Scientists Annual Meeting, Los Angeles Convention Center, Los Angeles, CA, November 8-12, 2009; Accepted for Presentation.
47. Repka MA, Repka, Staci L., McGinity, James W. 2002. Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof; United States Patent #6,375,963, April 23, 2002.
48. Prodduturi S, Manek RV, Kolling WM, Stodghill SP, Repka MA 2004. Water vapor sorption of hot-melt extruded hydroxypropyl cellulose films: effect on physico-mechanical properties, release characteristics, and stability. J Pharm Sci 93(12):3047-3056.
49. Repka MA, ElSohly MA, Munjal M, Ross SA 2006. Temperature stability and bioadhesive properties of delta9-tetrahydrocannabinol incorporated hydroxypropylcellulose polymer matrix systems. Drug Dev Ind Pharm 32(1):21-32. (Pubitemid 43220911)
50. Repka MA, Prodduturi S, Stodghill SP 2003. Production and characterization of hot-melt extruded films containing clotrimazole. Drug Dev Ind Pharm 29(7):757-765. (Pubitemid 36899882)
51. Repka MA, Mididoddi PK, Stodghill SP 2004. Influence of human nail etching for the assessment of topical onychomycosis therapies. Int J Pharm 282(1-2):95-106.
52. van Laarhoven JA, Kruft MA, Vromans H 2002. In vitro release properties of etonogestrel and ethinyl estradiol from a contraceptive vaginal ring. Int J Pharm 232(1-2):163-173.